The report is built for ultrasound OEM executives, strategy and corporate development teams, service and aftermarket leaders, providers, investors, and AI and workflow vendors adjacent to imaging. It brings hardware, installed-base economics, service, core AI recurring revenue, the broader AI bridge, market-structure views, competitive architecture and Markintel® strategic frameworks into one reconciled decision model.
AI is treated as a core commercialization layer across acquisition guidance, reporting, quantification, cloud orchestration and enterprise governance. The analysis explains where value is forming, how it is monetized, how competition is reorganizing, and which commercial moves matter most over the next decade.
Key Questions Answered
- How fast is ultrasound broadening into new users and care settings compared with how fast it is premiumizing?
- Which hardware segments carry revenue growth, and which carry unit and access expansion?
- How much of the value pool is moving above hardware into service, workflow, governance and cloud-linked software?
- Which AI streams (hardware, software, services, and cloud and pay-per-use) gain the most mix through 2035E?
- How do North America, Europe, APAC, Latin America, and the Middle East and Africa differ in scale, growth and monetization quality?
- Which companies are best placed in the installed-base, portable and handheld, AI and workflow, and China battlegrounds?
Market Snapshot
Ultrasound is broadening faster than it is premiumizing. Unit shipments grow much faster than systems revenue, so the market is adding many more devices into many more care settings than a revenue-only view suggests.Premium and midrange carts remain the value core for advanced departmental work in cardiology, interventional imaging and higher-acuity women's health. Compact and portable consoles become the largest revenue segment by 2035E, while handheld and POCUS devices post the largest gain in unit share. Ecosystem revenue grows as service, workflow and AI-linked monetization thicken around the installed base.
Key Market Trends
1. The market is splitting between premium depth and distributed access. Premium carts stay critical where image quality and departmental integration matter most, while compact, portable and handheld systems widen the user base and reset expectations on mobility and software support.2. Value is moving above the probe. Acquisition guidance, auto-quantification, structured reporting, archiving, QA, governance and fleet-level integration increasingly hold the durable advantage, with the console acting as the platform for recurring layers.
3. AI monetization is shifting toward cloud, services and governance. Software stays the largest AI stream, but cloud and pay-per-use gain the most mix as value moves to cloud review, governed deployment and utilization-linked contracts.
4. Geography splits between scale, growth and monetization quality. North America remains the largest and richest pool, Europe a recurring-rich installed base and APAC the fastest-growing major region; Latin America and the Middle East and Africa matter for access, value tiers and service-network execution.
5. AI adoption depends on workflow fit and evidence. Use cases scale when clinical evidence, workflow insertion, data governance and ROI proof are strong enough for providers and OEM channels to turn them into repeatable contracts.
6. Control-plane ownership is the next moat. Durable advantage increasingly sits with companies that control distribution and workflow, or that partner effectively into those layers.
Competitive Structure
Competition is read through four executive battlegrounds: installed-base and premium-system control; portable and handheld access expansion; AI and workflow control; and China as a parallel competitive system. The report maps the ecosystem into seven competitive clusters: systems OEMs and platform incumbents; portable, compact and POCUS hardware; handheld and home-use ultrasound; AI acquisition, interpretation, workflow and decision support; frontier, wearable, hybrid, therapeutic and interventional ultrasound; semiconductor, transducer and enabling technology; and China-specific vendors and the local ecosystem.Company spotlights cover 93 companies, including GE HealthCare, Philips, Mindray, Samsung Medison, Siemens Healthineers, Canon Medical Systems, FUJIFILM Sonosite, SonoScape, Esaote, United Imaging Healthcare, Butterfly Network, Clarius Mobile Health, Exo, UltraSight, BrightHeart, Us2.ai, AS Software and Sonio.
What's Inside
Core model, 2024A-2035E: Systems revenue, unit shipments and installed base by hardware segment (premium cart, midrange cart, value cart, compact and portable console, handheld and POCUS), plus service and aftermarket revenue, core AI recurring revenue and the AI bridge by stream.Market-structure views: End-market, clinical application, purchase model, operating model and AI capability mix.
Markintel® strategic frameworks: M³ Market Momentum Matrix, M-TEM, T-DIC, Solution Adoption & Growth Matrix, AI Use-Case Monetization Architecture, GTM Growth-Maturity Matrix, Ecosystem Collaboration Matrix and Partnering Decision Tree, ARC-Index, and the Upgrade & Package Ladder.
Executive guidance: Implications-to-action and signals to watch over the next 12 to 24 months.
Regional and country analysis: North America (United States, Canada), Europe (Germany, France, United Kingdom, Italy, Rest of Europe), APAC (China, Japan, India, Rest of APAC), Latin America, and the Middle East and Africa.
Who Should Read This Report
- Ultrasound OEM executives across strategy, product, services and corporate development
- AI acquisition, workflow, reporting and cloud vendors
- Enterprise imaging and interoperability platform vendors
- Provider procurement and imaging operations leaders
- Investors, banks and private equity
- Ecosystem partners in probes, components, workflow infrastructure and service
Why This Report
Most ultrasound studies treat AI as an add-on chapter. This report builds it into the market's commercial architecture and ties every view to the same reconciled totals, separating the conservative core AI recurring line from the broader AI bridge so readers can see where value can accumulate without double counting. The result supports product, pricing, packaging, partnership and regional decisions within one consistent structure.Companies Mentioned
- AISAP
- AS Software
- ASUS LU800
- Biotics AI
- Boston Scientific
- Brainsonix
- BrightHeart
- Butterfly Network
- Canon Medical Systems
- Caption Health
- Carthera
- Chison
- Clarius Mobile Health
- DeepHealth / See-Mode
- DeepSight Technology
- DiA Imaging Analysis
- Diagnoly
- DolphinSonic
- EchoNous
- EndoSound
- Esaote
- ESI
- Evident Vascular
- EXACT Therapeutics
- Exo
- Fiyano
- Flosonics Medical
- FUJIFILM / FUJIFILM Sonosite
- GE HealthCare
- Gestalta
- Healcerion
- HeartFocus / DESKi
- HeartLab
- HistoSonics
- Hitachi
- Huasheng Medical
- iCAD
- imec
- Infineon Technologies
- Intelerad Medical Systems
- Intelligent Ultrasound / Surgical Science
- iSono Health
- Koios Medical
- Konica Minolta
- Laza Medical
- MAUI Imaging
- MediReport
- Merge Labs
- MicroPort Lifesciences
- Mindray
- MyCardium AI
- NerveBlox
- NICAMED
- NVIDIA
- Openwater
- Oxailis
- OxSonics Therapeutics
- Petal Surgical
- Philips
- PIUR Imaging
- Pulsenmore
- Qure.ai
- RadNet / DeepHealth
- Resolve Stroke
- Rivanna Medical
- Samsung Medison
- Sanmai Technologies
- SecondWave Systems
- Seno Medical
- Shantou Ultrasound / SIUI
- Siemens Healthineers
- Softsonics
- SonALAsense
- Sonic Incytes
- Sonio
- SonoScape
- Sonus Microsystems
- SuperSonic Imagine
- ThinkSono
- TodoPocus
- TRS Technologies
- TSMC
- TTP
- UltraSight
- Ultrasound AI
- Ultromics
- United Imaging Healthcare
- Us2.ai
- Vave Health
- Ventripoint Diagnostics
- Verasonics
- Vermon
- Wandong Medical

